Shandong Chenghui Shuangda Pharma Achieves Resounding Success at Pharmaconex 2025 in Cairo

Chenghui Shuangda 17

September 2025, Cairo – As a regional industry cornerstone, the exhibition significantly strengthened our brand influence in the Middle East and African markets. The camera captures moments, whi...

Approval Announcement | Shandong Chenghui Shuangdas Topical API Crisaborole Successfully Upgraded to Category A

Chenghui Shuangda 41

【Breaking News】Shandong Chenghui Shuangda Pharmaceutical Co., Ltd.'s independently developed active pharmaceutical ingredient (API) Cliborol (Registration No.: Y20230000985) received approval from th...

Pioneering Milestone: Chinas First CEP Certification for Tetracaine HCl API Granted by EDQM

Chenghui Shuangda 47

We are proud to announce that our pharmaceutical ingredient Tetracaine Hydrochloride has been granted the Certificate of Suitability to the European Pharmacopoeia (CEP) by the European Directorate fo...

CPHI & PMEC Shenzhen 2025: Shandong Chenghui Pharma Showcases Cutting-Edge Solutions at Booth 9L39

Chenghui Shuangda 36

Shandong Chenghui Pharma Group cordially invites you to attend CPHI & PMEC Pharmaceutical Industry Exhibition (Shenzhen), which will be held grandly at Shenzhen Convention and Exhibition Center from ...

‌Join Us at Pharmaconex 2025 in Cairo – Shandong Chenghui Bridges Qilu and the Nile

Chenghui Shuangda 60

From 1 to 3 September 2025, Shandong Chenghui Pharmaceutical Group & Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. will showcase their high-end pharmaceutical raw materials and intermedia...

Successful Conclusion of CPHI China 2025: Shandong Chenghui Pharmaceutical Group Showcases Excellence

Chenghui Shuangda 53

Shanghai, June 26, 2025‌ – The three-day CPHI China exhibition concluded successfully at the Shanghai New International Expo Centre. Shandong Chenghui Pharmaceutical Group made an impressive display ...

Chenghui Pharma to Showcase Pharmaceutical Innovations at CPHI China 2025 (Booth W1A30）

Chenghui Shuangda 91

CPHI China 2025: Shandong Chenghui Pharmaceutical Group to Showcase Innovations at Booth W1A30 The global pharmaceutical industry's premier event, CPHI China International Pharmaceut...

‌Chenghui Pharma Wraps Up Spectacular Presence at 2025 API China Guangzhou

Chenghui Shuangda 54

‌Guangzhou in May was bustling with energy as Shandong Chenghui Pharmaceutical Group showcased its innovative pharmaceutical intermediates and specialty API products at the 92nd API China & PHARM...

API China 2025 Preview: Explore Chenghuis GMP-Certified Portfolio at 10.3E10

Chenghui Shuangda 237

‌Shandong Chenghui Pharmaceutical Group sincerely invites you to visit ‌the 92nd API China Exhibition‌ (Booth No.: 10.3E10) to explore new trends in pharmaceutical ingredients and manufacturing tech...

Exhibition Invitation|Shandong Chenghui Shuangda Pharmaceuticals will meet you at CPHI Japan 2025 in Tokyo, Japan.

Chenghui Shuangda 92

Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. cordially invites you to visit 2025 Pharmaceutical Ingredients Exhibition (CPHI Japan) in Tokyo, Japan. We are please...